Skip to main content
SURAKSHA DIAGNOSTIC LIMITED logo

SURAKSHA DIAGNOSTIC LIMITED — Investor Relations & Filings

Ticker · SURAKSHA ISIN · INE877V01027 LEI · 335800SJSOH7ZQHTPO56 BSE.NS Human health and social work activities
Open in API
Filings indexed 144 across all filing types
Latest filing 2025-07-03 Regulatory Filings
Country IN India
Listing BSE.NS SURAKSHA

About SURAKSHA DIAGNOSTIC LIMITED

https://www.surakshanet.com

Suraksha Diagnostic Limited is a prominent diagnostic healthcare service provider primarily operating in Eastern India. The company offers a comprehensive range of pathology and radiology services, including clinical laboratory tests, molecular diagnostics, and advanced imaging such as MRI, CT scans, ultrasound, and X-rays. It operates a network of diagnostic centers and polyclinics, providing integrated healthcare solutions that encompass specialized consultations and preventive health check-ups. The organization is recognized for its commitment to quality, maintaining international standards through NABL and CAP accreditations. By leveraging advanced medical technology and a robust logistics framework for home collection, the company serves a diverse patient base, focusing on accurate clinical outcomes and accessible diagnostic care.

Recent filings

Filing Released Lang Actions
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2025-07-03 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2025-07-03 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) informing about the closure of the trading window for insiders due to the upcoming declaration of unaudited quarterly financial results for the quarter ended 30 June 2025. It references compliance with SEBI regulations on insider trading and mentions that the date for the board meeting to approve the results will be informed later. The document does not contain any financial data or results itself, nor does it include a report or detailed financial analysis. It is a regulatory announcement related to trading restrictions ahead of financial results disclosure. The document length is short (2397 characters), and it serves as an intimation rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-06-20 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) disclosing the schedule of meetings with analysts and institutional investors. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events or information. The content is about informing the exchanges and public about upcoming investor meetings, explicitly stating that no unpublished price sensitive information will be shared. The document is short (2442 characters) and does not contain any financial data, results, or detailed reports. It is an announcement of a meeting schedule rather than a financial report or detailed investor presentation. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-06-19 English
Resignation
Regulatory Filings
2025-06-06 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings conference call held by Suraksha Diagnostic Limited on May 30, 2025, discussing the financial results for the quarter and full fiscal year ended March 31, 2025. It includes management commentary on financial performance, operational highlights, strategic acquisitions, and a Q&A session with analysts. The presence of detailed financial figures, management discussion, and Q&A indicates this is a full transcript of an earnings call rather than a brief earnings release or a simple announcement. The document also references the availability of the transcript as per regulatory requirements. Therefore, the document fits the definition of a Call Transcript (CT).
2025-06-05 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.